Physician profile
Richard H Hoffman
NPI 1255426029
$1,189.97
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $12.84 · 2021: $328 · 2022: $480 · 2023: $200 · 2024: $35.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $348.96 | 2021-2023 | |
| Lilly USA, LLC | $202.42 | 2019-2023 | Mounjaro, Trulicity, Emgality |
| Novo Nordisk INC | $202.22 | 2019-2023 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.58 | 2019-2023 | Jardiance |
| Abbott Laboratories | $65.00 | 2021-2024 | Freestyle Libre 3 |
| Lifescan, INC. | $54.96 | 2022 | |
| Sanofi-Aventis U.S. LLC | $29.46 | 2021 | |
| Allergan, INC. | $24.26 | 2019 | |
| Corium, LLC | $21.96 | 2022 | |
| Dexcom, INC. | $21.74 | 2024 | Dexcom G6 Transmitter |
| Amneal Pharmaceuticals LLC | $19.63 | 2022 | |
| Harmony Biosciences LLC | $17.50 | 2023 | Wakix |
| Gilead Sciences, INC. | $15.30 | 2019 | |
| Glaxosmithkline, LLC. | $12.84 | 2020 | |
| Dynavax Technologies Corporation | $12.31 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $0.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.